Candel therapeutics and idea pharma announce strategic partnership to advance path-to-market commercialization efforts for can-2409

Needham, mass., march 20, 2025 (globe newswire) -- candel therapeutics, inc. (candel or the company) (nasdaq: cadl), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, together with idea pharma, a division of sai medpartners (idea), a pioneering biopharmaceutical strategy consultancy, today announced a strategic commercial partnership.
CADL Ratings Summary
CADL Quant Ranking